Showing 181-190 of 356 grants

Title Institution Researcher Program Duration Total Award Amount
Growing Beta Cell Replacement in T1D by Tolerizing Stem Cell-Derived Islets Regents of the University of Minnesota Bernhard Hering Cures 01-August-2025 to 31-July-2027 $688.430,02
Employing PD-L1-Modified Biomaterials to Induce Islet Allograft Tolerance Following Perihepatic Transplantation in Nonhuman Primates Regents of the University of Minnesota Melanie Graham Cures 01-April-2025 to 31-March-2027 $918.744,88
JDRF Cures Patient Preference Study in Type 1 Diabetes RTI International Kelley Myers Transportfolio 01-July-2023 to 31-March-2027 $831.600,00
PREdictors for DiabetIC Ketoacidosis at Diagnosis of Type 1 Diabetes (The PREDICT study) Rutgers, The State University of New Jersey Chintan Dave Cures 01-August-2022 to 31-July-2026 $695.404,04
Building the Evidence to Address Disparities in Young children with Type 1 Diabetes: BEADY-T1D Stanford University Ananta Addala Improving Lives 01-February-2025 to 31-January-2029 $943.983,20
Development of ultrarapid insulin for automated insulin dosing systems Stanford University Danny Hung-Chieh Chou Improving Lives 01-July-2026 to 30-June-2028 $1.036.315,00
Development of an injectable immunomodulatory niche technology for induction of immune tolerance to islet cell transplants Stanford University Eric Appel Cures 01-January-2025 to 31-December-2026 $600.000,00
Ultrafast Insulin-Pramlintide Co-formulations Stanford University Eric Appel Improving Lives 01-September-2022 to 31-December-2026 $794.960,90
Endothelial cells for islet replacement in diabetes Stanford University Martin Neukam Cures 01-April-2024 to 31-March-2027 $251.600,00
Optimized bone marrow conditioning and tolerance assays to advance cell-based therapies for diabetes Stanford University Stephan Ramos Cures 01-March-2026 to 28-February-2029 $285.000,00